FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Massachusetts deputy director arrested in cocaine case, raising concerns about a breach of public trust.
FDA updates biosimilars guidance to streamline approvals and boost competition, aiming to cut regulatory barriers and speed lower-cost options to market.
Massachusetts deputy director arrested in cocaine case, raising concerns about a breach of public trust.